| MSD Merck Sharp & Dohme AG - M-M-RVAXPRO, Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | | 00703 | | 01 | | M-M-RVAXPRO | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | | J07BD52 | | Measles, Combinations with Mumps and Rubella, Live Attenuated | | 13.02.2007 | | |
| | Composition | | Vaccinum attenuatum: virus morbilli vivus (Stamm Edmonston-Enders) min. 1000 U., virus parotitis vivus (Stamm Jeryl Lynn) min. 12500 U., virus rubella vivus (Stamm Wistar RA 27/3) min. 1000 U., gelatina hydrolysata, medium 199, minimal essential medium (MEM), natrii hydrogenoglutamas monohydricus, neomycinum, phenolsulfonphthaleinum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, natrii hydrogenocarbonas, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, sorbitolum 14.5 mg, saccharum, albuminum humanum, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 2.45 mg et kalium 0.09 mg.
Solvens: aqua ad iniectabile. | | Packungsbestandteile | | Solvens | | | aqua ad iniectabile 0.5 ml | | | | | | BAG: Active Agent | Dose |
|---|
| | 1000 U | | | 12500 U | | | 1000 U |
|
| Lyophilisate and solvent | | | | | | | | Active Agent | Dose | additional_information |
|---|
| | 1000 U | Vaccinum attenuatum | | | 12500 U | | | | 1000 U | |
| | BAG: Active Agent | Dose |
|---|
| | 1000 U | | | 12500 U | | | 1000 U |
| | | | Inactive agents | Dose |
|---|
| | | | Human Albumin | | | Dipotassium Phosphate Anhydrate | | | Disodium Phosphate Dihydrate | | | | | | Potassium Dihydrogenophosphate | | | | 199 | | | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydrogen Carbonate | | | | | | Sodium Hydroxide | | | Neomycin | | | | | | Saccharum | | | Sorbitol | 14.5 mg |
| |
| Solvens | | | aqua ad iniectabile | | | | | | BAG: Active Agent | Dose |
|---|
| | 1000 U | | | 12500 U | | | 1000 U |
|
| |
|
